# 3D Imaging Drug Design and Development, Little Rock, AR – FDA Inspections

Source: https://www.keypedia.com/companies/3d-imaging-drug-design-and-development/52a34c85-0fab-4e15-8980-ba031bb418ce

> Inspection records and compliance data for 3D Imaging Drug Design and Development in Little Rock, Arkansas. 4 FDA inspections on record (2 OAI), 3 Form 483s, 1 warning letter, last inspected June 13, 2025.

---

## Details

- Name: 3D Imaging Drug Design and Development
- FEI Number: 3009143510
- Business Operations: POSITRON EMISSION TOMOGRAPHY DRUG PRODUCTION
- Address Line 1: 9015 Carti Way
- City: Little Rock
- State: Arkansas
- Zip Code: 72205
- Country Name: United States
- Address: 9015 Carti Way, Little Rock, Arkansas 72205, United States
- Country: United States

## Related Documents

- [483 - 3D Imaging Drug Design and Development - 2025-06-13](https://www.keypedia.com/records/483/3d-imaging-drug-design-and-development/e003cf9e-5c6f-4f14-a5d1-57a75f8e74b4) — source: FDA, date: June 13, 2025
- [WARNING_LETTER - 3D Imaging Drug Design and Development - 2025-06-13](https://www.keypedia.com/records/warning_letter/3d-imaging-drug-design-and-development/c5f0dae6-b3e5-47c5-bd2e-efbbd2786f38) — source: FDA, date: June 13, 2025
- FDA Inspection 1272748 - 3D Imaging Drug Design and Development - 2025-06-13 — classification: Official Action Indicated (OAI), source: FDA, date: June 13, 2025
- [FDA Inspection 1272748 - 3D Imaging Drug Design and Development - 2025-06-13](https://www.keypedia.com/records/fda_inspections/3d-imaging-drug-design-and-development/110c05b6-92ad-4ba6-a7b3-089d7293b2a5) — classification: Official Action Indicated (OAI), source: FDA, date: June 13, 2025
- [483 - 3D Imaging Drug Design and Development - 2025-06-09](https://www.keypedia.com/records/483/3d-imaging-drug-design-and-development/d5154a2b-5adb-43eb-b8e3-da4daa333ba5) — source: FDA, date: June 9, 2025
- [483 - 3D Imaging Drug Design and Development - 2024-01-31](https://www.keypedia.com/records/483/3d-imaging-drug-design-and-development/b21c2326-aca9-4c9b-861d-baa1a8c486b6) — source: FDA, date: January 31, 2024
- FDA Inspection 1228168 - 3D Imaging Drug Design and Development - 2024-01-31 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 31, 2024
- [FDA Inspection 1228168 - 3D Imaging Drug Design and Development - 2024-01-31](https://www.keypedia.com/records/fda_inspections/3d-imaging-drug-design-and-development/b62a272a-50d6-4a9e-99be-3d3008f0eb1d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 31, 2024
- [FDA Inspection 1076821 - 3D Imaging Drug Design and Development - 2019-01-18](https://www.keypedia.com/records/fda_inspections/3d-imaging-drug-design-and-development/fa006bb2-0ae3-48d4-a205-c84f0d757d0a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 18, 2019
- FDA Inspection 1009371 - 3D Imaging Drug Design and Development - 2017-04-20 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 20, 2017
- FDA Inspection 1009371 - 3D Imaging Drug Design and Development - 2017-04-20 — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 20, 2017
- [FDA Inspection 1009371 - 3D Imaging Drug Design and Development - 2017-04-20](https://www.keypedia.com/records/fda_inspections/3d-imaging-drug-design-and-development/64a48028-799f-499d-8317-f10bb4b44bfe) — classification: Official Action Indicated (OAI), source: FDA, date: April 20, 2017

## Related Companies

- [PETNET Solutions, Inc.](https://www.keypedia.com/companies/petnet-solutions-inc/2cbae8a1-124d-441c-aead-a95a860e4b1e)
- [Sofie Co.](https://www.keypedia.com/companies/sofie-co/0460328d-5815-4776-911a-a555b542af05)
- [Washington University School of Medicine](https://www.keypedia.com/companies/washington-university-school-of-medicine/b4b3b2ae-0529-4621-84f0-f9d4b60a13ef)
- [UCLA Biomedical Cyclotron](https://www.keypedia.com/companies/ucla-biomedical-cyclotron/c81bfa21-90ca-4cbb-b13f-8158b4bcaa44)
- [Pharmalogic Salt Lake City, LLC](https://www.keypedia.com/companies/pharmalogic-salt-lake-city-llc/bbcf3e35-8b85-402e-bb8a-33859fbabb46)
- [Pharmalogic Los Angeles, LLC](https://www.keypedia.com/companies/pharmalogic-los-angeles-llc/417391fc-7718-4078-9ef6-37bcae858bc1)
- [SOFIE Co. dba SOFIE](https://www.keypedia.com/companies/sofie-co-dba-sofie/2788a42c-0f99-4a95-8de3-ef2e88c93110)
- [Ionetix Corporation](https://www.keypedia.com/companies/ionetix-corporation/a014fcbf-0e12-434a-bb00-adb100627897)
- [Johns Hopkins University PET Center](https://www.keypedia.com/companies/johns-hopkins-university-pet-center/184f7e43-e0b8-4314-a1df-0341eadb9ce5)
- [Precision Nuclear of Virginia, LLC](https://www.keypedia.com/companies/precision-nuclear-of-virginia-llc/2e47b9e0-b7b2-46c4-a5c3-d77e3331b114)

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/michelle-j-hines/c8087e41-6b8a-4b9a-92ad-bba500ce6fee)
- [Margaret M. Annes](https://www.keypedia.com/people/margaret-m-annes/e528fbbe-2a4c-4697-9256-b7f2d0bcd279)
- [Marc S. Berridge](https://www.keypedia.com/people/marc-s-berridge/f9aaa564-752d-4645-9115-f66bfefb3e61)